Playback speed
10 seconds
This video is featured in the 2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "Biomarker Analysis & Updated Clinical Outcomes - Neoadjuvant Systemic Treatment With Nivolumab and Relatlimab in Surgically Resectable Melanoma"
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
Liz Burton
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
Liz Burton
0 views
July 22, 2024
Comments 0
Login to view comments.
Click here to Login